Conclusion: there should be full public disclosure of scientific authors' commercial holdings.
Why? Authors and reviewers in scientific journals have praised companies in which they have substantial investments. This calls into question the integrity of scientific inquiry because these scientists have a potential conflict of interest.
We are looking for an answer choice that conforms most closely to the principle illustrated by the argument.
Well, what's the principle? When there is a potential conflict of interest, there should be full public disclosure.
Answer choice (E) best conforms to this since financial advisers who receive incentives for promoting investments will have a potential conflict of interest, therefore they should disclose this, i.e. "Financial advisers should inform their clients about any incentives the advisers receive for promoting investments in particular companies."
Hope that clears things up! Please let us know if you have any other questions.
